As the SARS-COV-2 Omicron subvariants BA.4 and BA.5 make their way across the EU and the US, China-based Joysbio has dev...
US-based Ainos, a diversified medtech company focused on the development of novel point-of-care testing, low-dose interf...
Japan's H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio Holdings, Inc., and Belgium-based ADx NeuroS...
South Korea Ministry of Food and Drug Safety (MFDS) has approved the Agilent Technologies PD-L1 IHC 22C3 pharmDx as a co...
The synergy of AI and digital pathology has opened a world of image-based possibilities that can transform disease diagn...
Sydney based Healthcare AI firm annalise.ai has partnered with Fujifilm Australia for the distribution of its decision s...
Us2.ai, a Singapore-based medtech firm has received CE Mark clearance for Us2.v1, a completely automated decision suppor...
US-based Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, has announced a partnership...
MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, and A*STAR spinoff, focused on s...
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has unveiled a global initiative for ...
New Horizon Health and Prenetics has announced a strategic partnership to launch ColoClear by Circle, the "First Colorec...
Known as a pioneer in Asia's women's and foetal health industry, Singapore-based diagnostics developer, I...
Hitachi High-Tech Corporation, headquartered in Tokyo, Japan, has entered into a strategic partnership with In...
KYAN Therapeutics (a Delaware Corporation headquartered in Singapore) teams up with Curie Oncology to offer its novel an...
Taiwan's iXensor, the pioneer of mobile health, has announced that Rohto Pharmaceutical Co., Ltd, a multinational pharma...
US-based Zymo Research is making a strategic investment to acquire an interest in Star Array, a privately owned, biomedi...
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has announced the development of the ...
VolitionRx, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diag...